Cancer doctors from across the U.S. are lending their voices to a new advocacy campaign to end drug shortages. Led by the Association for Clinical Oncology (ASCO), nearly 500 oncology professionals have signed an open letter to Congress and the administration highlighting the severe impact of drug shortages on cancer care and urging swift action from lawmakers.
April 17, 2024
March 28, 2024
Today the Department of Health and Human Services (HHS), Department of Labor and the Treasury Department finalized a rule regulating the availability of short-term limited duration insurance (STLDI) plans. The rule would restrict the availability of these plans to no more than four months.
March 22, 2024
Congress is expected to vote on a spending package March 22 that will fund the federal government, including the National Institutes of Health (NIH) and National Cancer Institute (NCI), through September 30— the end of the 2024 Fiscal Year.
March 7, 2024
The Association for Clinical Oncology (ASCO) is calling on President Biden to continue to prioritize access to high-quality, equitable cancer care in his State of the Union address.
February 6, 2024
Julie R. Gralow, MD, FACP, FASCO, Chief Medical Officer & Executive Vice President of the Association for Clinical Oncology (ASCO), will testify before the full House Committee on Ways and Means on the crisis of ongoing cancer drug shortages. Dr. Gralow will share ASCO members’ firsthand experiences managing clinical care in the face of severe shortages. She will also urge Congress to take action to help mitigate the problem.
January 17, 2024
The Centers for Medicare & Medicaid Services (CMS) issued its rule requiring federal health plans—including Medicare Advantage plans, Medicaid plans, and Qualified Health Plans (QHP) on Federally Facilitated Exchanges (FFEs)— to establish an electronic prior authorization process that will be integrated into providers’ workflows.
November 16, 2023
Congress passed a two-tiered continuing resolution (CR) on November 15, 2023, extending FY 2023 federal funding levels until February 2, 2024, for all Department of Health and Human Services agencies, including the National Institutes of Health (NIH) and the National Cancer Institute (NCI). The president is expected to sign the bill.
October 17, 2023
The American Society of Clinical Oncology and Association for Clinical Oncology (ASCO) are urging members of the Senate Committee on Health, Education, Labor, and Pensions to approve the nomination of Monica M. Bertagnolli, MD, FACS, FASCO, as the next Director of the National Institutes of Health (NIH) during its October 18, 2023, hearing.
September 28, 2023
ASCO has released a statement on the how an impending government shutdown will impact cancer research and scientific progress.
September 14, 2023
The House Energy and Commerce Subcommittee on Health will hold a hearing today on several bills aimed at addressing the ongoing U.S. drug shortage crisis. Many of the bills contain provisions the Association for Clinical Oncology supports as effective means to mitigate and prevent drug shortages and promote a more resilient supply chain in the future.
July 7, 2023
The Department of Health and Human Services (HHS), Department of Labor and the Treasury Department issued a proposed rule regulating the availability of short-term limited duration insurance (STLDI) plans. The rule would restrict the availability of these plans to no more than four months.
May 31, 2023
Today the U.S. House is poised to vote on legislation to raise the nation’s debt ceiling. The proposal includes flat funding for non-defense discretionary spending in FY 2024 and a 1% funding increase in FY 2025. This would considerably restrict potential resources for the National Institutes of Health (NIH) and National Cancer Institute (NCI) at a time when scientists are on the cusp of so many promising cancer discoveries.
May 1, 2023
ALEXANDRIA, Va. – More than 150 members of the Association of Clinical Oncology (ASCO), the leading professional organization for oncology professionals, will meet with Members of Congress on Tuesday urging them to make cancer care a top priority.
“Lawmakers have a profound effect on cancer patients and their doctors. From funding the research that leads to new groundbreaking treatments, to ensuring those treatments are covered by insurance and accessible and affordable to patients; lawmakers play a pivotal role,” said ASCO Board Chair Lori J. Pierce, MD, FASTRO, FASCO.
April 19, 2023
Today members of the U.S. House of Representatives unveiled a proposed legislative deal to reduce federal spending in exchange for raising the nation’s debt ceiling. The proposal includes significant funding cuts to federal agencies, which would include resources for the National Institutes of Health (NIH) and National Cancer Institute (NCI). It also proposes adding work requirements for Medicaid enrollment.
A statement from Dr. Julie Gralow, Chief Medical Officer and Executive Vice President, Association of Clinical Oncology follows:
March 23, 2023
ASCO Member Testifies Before Congress Urging Significant Increase in Federal Cancer Research Funding
Dr. Brian Persing, a medical oncologist and hematologist in Mobile, Alabama and member of the Association of Clinical Oncology (ASCO), the world’s leading professional organization representing nearly 45,000 oncology professionals, will testify before the House Appropriations Subcommittee on Labor Health and Human Services and Education today in support of increased federal funding for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Centers for Disease Control and Prevention (CDC) Division of Cancer Prevention and Control. He will also advocate for robust funding of the Advanced Research Projects Agency for Health (ARPA-H).
Pages |